| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/21/2011 | WO2010141716A3 Methods and materials for diagnosing light chain amyloidosis |
| 04/21/2011 | WO2010141469A9 Protein biomarkers and therapeutic targets for autoimmune and alloimmune diseases |
| 04/21/2011 | WO2010138967A3 Method for evaluating renal function |
| 04/21/2011 | WO2010138960A3 Methods and systems for single-molecule rna expression profiling |
| 04/21/2011 | WO2010138851A3 E-cadherin as a biomarker of gastroesophageal reflux disease |
| 04/21/2011 | WO2010138814A3 Disrupting fcrn-albumin interactions |
| 04/21/2011 | WO2010138803A3 Herv-k antigens, antibodies, and methods |
| 04/21/2011 | WO2010138621A3 Diagnosing and treating iga nephropathy |
| 04/21/2011 | WO2010136996A3 Microflow analytical system |
| 04/21/2011 | WO2010135717A3 Complement assays and uses thereof |
| 04/21/2011 | WO2010135574A3 Systems and methods for determining the percentage of glycated hemoglobin |
| 04/21/2011 | WO2010135391A3 An improved method for diagnosing or predicting short stature in humans |
| 04/21/2011 | WO2010129441A3 Method for separating stem cells from their more differentiated progeny using microfluidic devices |
| 04/21/2011 | WO2010129270A3 Profiling fragments of elastic fibers and microfibrils as biomarkers for disease |
| 04/21/2011 | WO2010127843A3 Method and device for determining reflection coefficients on thin layers |
| 04/21/2011 | WO2010124812A3 Identification of tumor-associated markers for diagnosis and therapy |
| 04/21/2011 | WO2010115080A3 Self-assembling peptides bearing organic electronic functionality and applications employing the same |
| 04/21/2011 | WO2010111595A3 Markers related to age-related macular degeneration and uses therefor |
| 04/21/2011 | WO2010080640A8 A ph modulation method to detect ligand-receptor binding |
| 04/21/2011 | WO2010008588A3 Modulation of gm98 (mrf) in remyelination |
| 04/21/2011 | US20110093964 Uranium-chelating peptides and uses thereof |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110093960 Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions |
| 04/21/2011 | US20110093298 System for animal health diagnosis |
| 04/21/2011 | US20110093214 Dangerous substance detection system |
| 04/21/2011 | US20110093211 Method for Processing Protein Data |
| 04/21/2011 | US20110093208 Least-square deconvolution (lsd): a method to resolve dna mixtures |
| 04/21/2011 | US20110093205 Proteomics previewer |
| 04/21/2011 | US20110093204 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110092572 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 04/21/2011 | US20110092551 Dual-acting imidazole antihypertensive agents |
| 04/21/2011 | US20110092508 Biomarkers of tumor pharmacodynamic response |
| 04/21/2011 | US20110092452 Compositions and methods for diagnosing and treating pancreatic cancer |
| 04/21/2011 | US20110092445 Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses |
| 04/21/2011 | US20110092440 Method of regulating cell growth using a proteasome inhibitor |
| 04/21/2011 | US20110092388 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/21/2011 | US20110092387 Expression profiling using microarrays |
| 04/21/2011 | US20110092386 Isolating biological modulators from biodiverse gene fragment libraries |
| 04/21/2011 | US20110092378 Isolation and use of solid tumor stem cells |
| 04/21/2011 | US20110091997 Immunosuppressant drug extraction reagent for immunoassays |
| 04/21/2011 | US20110091996 Organic non-sugar compounds for protection of biologically active molecules and conjugate labels and methods of use thereof |
| 04/21/2011 | US20110091995 Ehrlichia canis DIVA (Differentiate Infected from Vaccinated Animals) |
| 04/21/2011 | US20110091994 Methods for Screening Compounds for Treating and/or Preventing an Hepatitis C Virus Infection |
| 04/21/2011 | US20110091993 Method for quantification of soluble lr11 |
| 04/21/2011 | US20110091992 CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT |
| 04/21/2011 | US20110091991 Protein Biomarkers for Alzheimer's Disease Detection |
| 04/21/2011 | US20110091990 Device and methods for collection of biological fluid sample and treatment of selected components |
| 04/21/2011 | US20110091988 Sample processing unit and sample processing method |
| 04/21/2011 | US20110091986 Chemical analyser, method for sample-based analysis, device for handling cuvettes, and loading method |
| 04/21/2011 | US20110091982 Detection and Quantification of Anions |
| 04/21/2011 | US20110091981 Mass Spectrometry Quantitation of P450 Isoforms in Hepatocytes |
| 04/21/2011 | US20110091979 Tracing Coalbed Natural Gas - Coproduced Water Using Stable Isotopes of Carbon |
| 04/21/2011 | US20110091968 Monoclonal antibody specific to both human interferon-alpha subtype alpha 8 and its mutant proteins |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091917 Method of measuring lipid in specific lipoprotein |
| 04/21/2011 | US20110091915 IgA Nephropathy Testing Method and Test Kit |
| 04/21/2011 | US20110091914 Immunological Test Element with Improved Control Zone |
| 04/21/2011 | US20110091913 Drug safety test using pentraxin-3 (ptx-3) |
| 04/21/2011 | US20110091912 High molecular weight ngal as a biomarker for chronic kidney disease |
| 04/21/2011 | US20110091911 Antibodies, systems and methods for determining relative hemolytic index |
| 04/21/2011 | US20110091910 Novel assay |
| 04/21/2011 | US20110091909 Stabilizing Agents and Capture Ligands for Use in Assays Measuring Analyte Concentrations |
| 04/21/2011 | US20110091908 Early prostate cancer antigen-2: a novel serum specific marker for prostate cancer detection |
| 04/21/2011 | US20110091907 Method for detection of liver cancer cell using anti-glypican-3 antibody |
| 04/21/2011 | US20110091906 Immuno gold lateral flow assay |
| 04/21/2011 | US20110091905 Biochip and method of detecting reaction from the same |
| 04/21/2011 | US20110091904 Method for determination of affinity and kinetic constants |
| 04/21/2011 | US20110091903 Method of analyzing a sample for a bacterium using diacetylene-containing polymer sensor |
| 04/21/2011 | US20110091902 Method of assaying physiologically active substance of biological origin, kit for assaying physiologically active substance of biological origin and apparatus for assaying physiologically active substance of biological origin |
| 04/21/2011 | US20110091901 Vectors and Methods for Screening Cells for High Expression of Protein of Interest (POI) |
| 04/21/2011 | US20110091893 Biosensors for detecting macromolecules and other analytes |
| 04/21/2011 | US20110091892 Methods for the Diagnosis and Treatment of Lung Cancer |
| 04/21/2011 | US20110091888 Use of cathepsin c |
| 04/21/2011 | US20110091887 Method for detection of methylcytosine using photoresponsive probe |
| 04/21/2011 | US20110091881 Mycobacterial genes down-regulated during latency |
| 04/21/2011 | US20110091878 Dairy cattle breeding for improved milk production traits in cattle |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091870 Multisite biosensor and associated method |
| 04/21/2011 | US20110091868 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 04/21/2011 | US20110091865 Measuring multiple analytes over a broad range of concentrations using optical diffraction |
| 04/21/2011 | US20110091864 Device And Use Thereof |
| 04/21/2011 | US20110091526 Parasite Vaccine |
| 04/21/2011 | US20110091495 Hcv e2 construct compositions and methods |
| 04/21/2011 | US20110091482 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |
| 04/21/2011 | US20110091481 Biomarkers for predicting response to immunosuppressive therapy |
| 04/21/2011 | US20110091480 Antigen-Binding Proteins Targeting S. Aureus Orf0657n |
| 04/21/2011 | US20110091479 Novel anti-igf-ir antibodies and uses thereof |
| 04/21/2011 | US20110091476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091467 Compositions and methods for modulating dopamine neurotransmission |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091454 Methods and systems for annotating biomolecular sequences |
| 04/21/2011 | US20110091449 Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies |
| 04/21/2011 | US20110091444 Methods and compositions for treatment and prevention of major depressive disorder |
| 04/21/2011 | US20110091439 Cosmetic use of acid ceramidase type proteins |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091387 Methods and compositions for reducing skin damage |
| 04/21/2011 | US20110091384 Biomarker for identification of melanoma tumor cells |
| 04/21/2011 | US20110091383 Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents |